FLT4 Antikörper
Kurzübersicht für FLT4 Antikörper (ABIN2154593)
Target
Alle FLT4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- VEGFR3 antibody was purified by immunoaffinity chromatography.
-
Immunogen
- VEGFR3 antibody was raised in Rabbit using the peptide sequence around aa 1279~1283 (L-A-S-E-E) derived from Human VEGFR-3 as the immunogen.
-
-
-
-
Applikationshinweise
- IF: 1:100-1:200, IHC: 1:50-1:100, WB: 1:500-1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- In liquid form PBS buffer (no MG2+ or Ca2+), pH 7.4, 150 mm NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze/thaw cycles
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
-
: "uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis." in: Nature communications, Vol. 9, Issue 1, pp. 5178, (2019) (PubMed).
-
: "uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis." in: Nature communications, Vol. 9, Issue 1, pp. 5178, (2019) (PubMed).
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Andere Bezeichnung
- VEGFR3
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Target
-